Baaritaanka HIV-ga ee HCV iyo HBSAG ee Degdegga ah ee Isku-dhafka ah ee Waraabaha
MACLUUMAADKA SOO SAARKA
| Lambarka Moodeelka | HBsAg/TP&HIV/HCV | Baakad | 20 Tijaabo/xirmo, 30 xirmo/CTN |
| Magaca | Baaritaanka Degdegga ah ee Isku-dhafka ah ee HBsAg/TP&HIV/HCV | Kala soocidda qalabka | Fasalka III |
| Astaamaha | Xasaasiyadda Sare, Hawlgal Fudud | Shahaadada | CE/ ISO13485 |
| Saxnaanta | > 97% | Muddada khaanadaha | Laba Sano |
| Habka cilmi-baarista | Dahabka Kolloidal | Adeegga OEM/ODM | La heli karo |
Sareynta
Waqtiga Tijaabada: 15-20 daqiiqo
Kaydinta: 2-30℃ / 36-86℉
Habka: Dahabka Colloidal
Sifo:
• Xasaasi sare
• natiijada akhrinta 15-20 daqiiqo gudahood
• Hawlgal fudud
• Saxnaan Sare
ISTICMAALKA LOOGU TALAGALAY
Qalabkani wuxuu ku habboon yahay go'aaminta tayada ee fayraska hepatitis B, spirochete syphilis, fayraska difaaca jirka ee aadanaha, iyo fayraska hepatitis C ee ku jira seeramka/plas-ka aadanaha.muunado dhiig oo dhan ah si loo ogaado fayraska hepatitis B, spirochete syphilis, fayraska difaaca jirka ee aadanaha, iyo caabuqyada fayraska hepatitis C. Natiijooyinka la helay waa in la bixiyaa.la falanqeyn karo iyadoo lala kaashanayo macluumaad kale oo caafimaad. Waxaa loogu talagalay in ay isticmaalaan xirfadlayaasha caafimaadka oo keliya.
Habka tijaabada
| 1 | Akhri tilmaamaha loogu talagalay isticmaalka iyo si adag u raac tilmaamaha loo baahan yahay ee loogu talagalay isticmaalka si looga fogaado saameynta saxnaanta natiijooyinka baaritaanka |
| 2 | Kahor baaritaanka, qalabka iyo muunadda waxaa laga soo saaraa xaaladda kaydinta waxaana la dheellitiraa heerkulka qolka oo calaamadee. |
| 3 | Jeexitaanka baakadda ee bacda aluminiumka ah, ka soo saar qalabka tijaabada oo calaamadee, ka dibna si toosan u dhig miiska tijaabada. |
| 4 | Shaybaarada serum/plasma ku shub dhibic la tuuri karo oo ku dar 2 dhibcood ceel kasta s1 iyo s2; ku dar 3 dhibcood ceel kasta s1 iyo s2 muunadaha dhiigga oo dhan ka hor intaadan ku darin 1 ilaa 2 dhibcood oo ah xalka biyo raacinta ceel kasta s1 iyo s2 ka dibna Waqtiga ayaa la bilaabayaa |
| 5 | Natiijooyinka baaritaanka waa in la fasiraa 15-20 daqiiqo gudahood, haddii natiijooyinka la turjumay ee ka badan 20 daqiiqo aysan ansax ahayn. |
| 6 | Fasiraadda muuqaalka waxaa loo isticmaali karaa fasiraadda natiijooyinka. |
Fiiro gaar ah: muunad kasta waa in lagu shubaa tuubooyin nadiif ah oo la tuuri karo si looga fogaado wasakhowga isdhaafka ah.
BANDHIGGA CAAFIMAADKA
| Natiijooyinka WIZ eeHBsag
| Natiijada tijaabada ee fal-galaha tixraaca | Heerka isku-dhacyada togan：99.06% (95% CI 96.64% ~99.74%) Heerka isku beegsiga taban：98.69% (95% CI96.68% ~99.49%) Wadarta heerka isku-dhaca：98.84% (95%CI97.50% ~99.47% | ||
| Togan | Taban | Wadarta | ||
| Togan | 211 | 4 | 215 | |
| Taban | 2 | 301 | 303 | |
| Wadarta | 213 | 305 | 518 | |
| Natiijooyinka WIZ eeTP
| Natiijada tijaabada ee fal-galaha tixraaca | Heerka isku-dhacyada togan：96.18% (95% CI 91.38% ~98.36%) Heerka isku beegsiga taban：97.67% (95% CI95.64% ~98.77%) Wadarta heerka isku-dhaca：97.30% (95% CI95.51% ~98.38%) | ||
| Togan | Taban | Wadarta | ||
| Togan | 126 | 9 | 135 | |
| Taban | 5 | 378 | 383 | |
| Wadarta | 131 | 387 | 518 | |
| Natiijooyinka WIZ eeHCV
| Natiijada tijaabada ee fal-galaha tixraaca | Heerka isku-dhacyada togan：93.44% (95% CI 84.32% ~97.42%) Heerka isku beegsiga taban：99.56% (95%CI98.42%~99.88%) Wadarta heerka isku-dhaca：98.84% (95% CI97.50% ~99.47%) | ||
| Togan | Taban | Wadarta | ||
| Togan | 57 | 2 | 59 | |
| Taban | 4 | 455 | 459 | |
| Wadarta | 61 | 457 | 518 | |
| Natiijooyinka WIZ eeHIV
| Natiijada tijaabada ee fal-galaha tixraaca | Heerka isku-dhacyada togan：96.81% (95% CI 91.03% ~98.91%) Heerka isku beegsiga taban：99.76% (95% CI98.68% ~99.96%) Wadarta heerka isku-dhaca：99.23% (95% CI98.03% ~99.70%) | ||
| Togan | Taban | Wadarta | ||
| Togan | 91 | 1 | 92 | |
| Taban | 3 | 423 | 446 | |
| Wadarta | 94 | 424 | 518 | |
